Sanro Health

What Sanro Health does

Sanro Health is a clinician-led technology company founded in 2021 by retina specialists Dr. Ashley Kras and Dr. Edward Korot. The company focuses on accelerating patient identification and recruitment for clinical trials by unifying electronic medical record (EMR) data with medical imaging through an AI-driven platform. The company's core product, Sanro Optimizer, is a SaaS platform that connects to existing clinical systems via interoperable standards and applies intelligent algorithms to evaluate medical images in real time, rank patients using criterion-level evaluation, and customize protocol-aligned modules for individual trials.

The platform is positioned as reducing site burden while delivering real-time insights to research teams, with stated capability to track patient status through enrollment and retention for future studies. Sanro Health serves three primary buyer segments: clinical trial sites that need to identify eligible patients within their workflow, pharmaceutical sponsors that need faster recruitment across multiple sites, and contract research organizations (CROs) that manage trial operations. The company pursues an enterprise field sales motion through demo-based engagement, with no publicly disclosed pricing. As of the available data, Sanro Optimizer is live in clinics and actively finding patients for ongoing trials, indicating early commercial deployment with no disclosed revenue, funding, customer count, or geographic footprint detail.

Name

Sanro Health

Legal name

Sanro Health

Website

https://sanrohealth.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Sanro Health develops Sanro Optimizer, an AI-powered clinical trial patient identification platform that unifies EMR and imaging data. Founded in 2021 by retina specialists, it serves trial sites, sponsors, and CROs through enterprise SaaS.

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• Clinical trial software
• Patient identification platform
• EMR imaging integration
• Clinical AI analytics
• Patient recruitment technology

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Sanro Optimizer Platform: SaaS platform subscription for clinical trial patient identification, connecting to existing EMR and imaging systems. Likely operates on a subscription model with enterprise contracts based on the sales motion and demo-based engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Sanro Health sells Sanro Optimizer, an AI-powered SaaS platform that unifies electronic medical record (EMR) and medical imaging data to identify and rank eligible patients for clinical trials. The platform connects securely to existing site systems, applies protocol-specific intelligent algorithms, and delivers real-time AI image analytics so research teams can prioritize the best-fit patients without adding operational burden to clinical sites. It is positioned for clinical trial sites, pharmaceutical sponsors, and Contract Research Organizations (CROs).

Product overview

Sanro Health offers a single unified product called Sanro Optimizer, an AI-powered clinical trial patient identification platform that connects EMR and medical imaging data with intelligent algorithms. The platform provides real-time AI image analytics, patient profile ranking by criteria-level evaluation, and customized protocol-aligned modules to help research teams quickly identify and recruit eligible patients for active trials.

Differentiator

Problem solved

Functional benefit

Brands

• Sanro Optimizer: A platform that unites EMR and imaging data with intelligent algorithms to help research teams identify patients quickly and confidently for clinical trials. Features include seamless EMR and imaging data connection, customized protocol-aligned modules, intelligent patient profiles ranked by criteria-level evaluation, and advanced AI image analytics in real-time.

Products and services

• Sanro Optimizer AI-powered clinical trial patient identification platform that unites EMR and imaging data with intelligent algorithms to help research teams identify and recruit eligible patients quickly and confidently. Connects securely to existing site systems, delivers real-time insights, ranks patients by criteria-level evaluation, and tracks status through enrollment and retention. Built for clinical trial sites, pharmaceutical sponsors, and CROs.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Deep 6 AI: Deep 6 AI is an AI-powered clinical trial patient identification platform that mines EHR data to match patients to trials. It is the closest direct peer to Sanro, operating in the same patient-recruitment category with an enterprise sales motion to sponsors and sites.
• Castor: Castor offers an eClinical platform combining EDC, ePRO, eConsent, and decentralized trial tooling, sold to sponsors, CROs, and academic sites. It overlaps Sanro at the site/sponsor interface for clinical trial data capture.
• Trial Library: Trial Library is a clinical trial recruitment platform using AI and EHR data to connect sponsors with eligible patients and community physicians. It directly overlaps Sanro's site/sponsor recruitment workflow.
• Mendel: Mendel applies AI to unstructured and structured clinical data (EHR, pathology, imaging) to identify patients for clinical trials and generate real-world data. Like Sanro, it focuses on AI-driven clinical trial patient matching and serves sponsors and CROs.
• TrialX: TrialX operates AI-driven clinical trial matching using EHR and patient-reported data, connecting patients and providers to relevant trials. It is a direct competitor in the AI patient identification space.

Broad incumbents

• TriNetX: TriNetX operates a global federated health research network used by sponsors and CROs for protocol design, site feasibility, and patient identification. It is a broad incumbent in the trial-feasibility and recruitment data layer.
• IQVIA: IQVIA is the largest clinical research services and technology provider, offering EDC, CTMS, and AI-enabled trial recruitment and real-world evidence solutions. It represents the broad incumbent against whom Sanro must position.
• Veeva Systems: Veeva's Vault Clinical suite includes EDC, CTMS, and eTMF used across life sciences R&D. It is an incumbent clinical trial technology platform adjacent to the workflow Sanro serves.
• Medidata (Dassault Systèmes): Medidata provides the industry-standard Rave EDC and a broad clinical trial cloud platform used by sponsors and CROs. While not focused on AI patient identification, it owns the trial data ecosystem Sanro integrates with.

Emerging players

• Paradigm Health: Paradigm Health builds clinical trial recruitment infrastructure connecting sponsors, sites, and patients via technology-enabled workflows. It is an emerging competitor in patient identification and trial access.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/sanro-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanro Health